This genetic context may help provide useful information for your provider's dosing strategy, though genetic variants do not predict exact medication response
Recent pharmacokinetic insights suggest that multi-incretin agonists may cross the blood-brain barrier and directly influence neuronal receptors and pathways, providing neuroprotection independent of peripheral glucose levels [33]
Previous studies have shown that GLP-1RAs are effective in reducing body weight and blood pressure in comparison to placebo 84,85
Diabetes (2009) 58(11):252535.10.2337/db08-1261 111 ChakrabortiCK
GLP-1 GLP-1GLP-1GLP-1 GLP- GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1GLP-1 GLP-1 11 GLP-1FDAEMAMFDS 2 GLP-1FDAEMAMFDS 2 GLP-1 GLP-1 1875 BMI18.515 2 Ai 2 FDAZepbound Ai GLP-1 2FDAEU27EMAMFDS GLP-1 or LINE 3 550 2 Ai 2 FDAEU27EMAMFDS 2
The team will review medical history, explain costs and monitoring, and personalise a treatment plan for your needs